ALEXZA PHARMACEUTICA ALXA (NASDAQ)

$ 5.30
19:09
Change: unch (unch%)
Volume: 85,572

Avg. Volume: 90039
P/E Ratio: 0
EPS (Annual): -1.89
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 31,160
Institutional Shareholders: 42.56%
Last: 5.30
Change: unch (unch%)
Prev. Close: 5.30
Open: 5.54
Day's Range: 5.17 - 5.65
52wk Range: 3.75 - 9.72
Market Value: 176,390
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -42.39%
Total Return Last 3 Years: -34.89%
Total Return Last 5 Years: -37.72%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ALXA

Alexza reports good results in schizophrenia study

(MOUNTAIN VIEW, Calif.)Alexza Pharmaceuticals said Tuesday its experimental drug significantly reduced symptoms of schizophrenia in a late-stage trial. The company reported that a study of 344 schizophre...READ MORE
Sep 02, 2008 7:40PM
Keywords: ALXA

Earnings roundup: BearingPoint, Energy Transfer Partners

Among the earnings stories for Monday, May 12, from AP Financial News: McLEAN, Va. (AP) _ BearingPoint Inc., a management and technology consultant, said Monday its first-quarter l...READ MORE
May 12, 2008 6:48PM
Keywords: BE, ETP, ALXA, PGIC, KNXA

Alexza 1Q loss widens on increased development costs

(MOUNTAIN VIEW, Calif.)Drug developer Alexza Pharmaceuticals Inc. said Monday that its first-quarter loss widened on increased research and development spending. The company lost $14.6 million, or 47 cen...READ MORE
May 12, 2008 5:23PM
Keywords: ALXA

Movers Roundup: Genzyme, SunPower

Among the stock activity stories for Tuesday, March 18, from AP Financial News: NEW YORK (AP) _ Shares of biotechnology company Genzyme Corp. are rising after the company reaffirme...READ MORE
Mar 18, 2008 6:26PM
Keywords: GENZ, SPWR, ALXA, AVR

Alexza Pharma Falls on Funding Concerns

(NEW YORK)Alexza Pharmaceuticals Inc. shares fell, and reached an all-time low amid concerns that the company lacks the funds needed to develop its drug candidates.READ MORE
Mar 18, 2008 2:08PM
Keywords: ALXA

Ahead of the Bell: Alexza

(NEW YORK)An RBC Capital Markets analyst said Friday that a deal between Alexza Pharmaceuticals Inc. and Endo Pharmaceuticals Holdings Inc. is "extremely valuable" for Alexza because of Endo...READ MORE
Dec 28, 2007 9:01AM
Keywords: ALXA, ENDP
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -18.50 18.67
MERCK CO INC -32.60 34.17
JOHNSON AND JOH +17.90 70.45
SCHERING PLOUGH -29.30 19.16
BRISTOL MYERS S -18.00 21.50